Wyeth, a Mumbai based multinational major, has announced better financial performance during the 16 months period ended March 2011. Its net profit touched to Rs.165.29 crore from Rs.59.01 crore in the previous year of 8 months period. Its net sales reached at Rs.636.48 crore for the 16 months period from Rs.286.36 crore in the eight months period of las year. On an annualised basis, the net sales increased by 11.1 per cent and net profit by 38 per cent.


The company declared equity dividend of 150 per cent for the financial year 2010-11 of 16 months period. Earlier, the management paid interim dividend of 70 per cent making aggregate dividend of 220 per cent for the year 2010-11. Despite strong financial performance and handsome dividend, the Wyeth scrip declined almost by Rs.23 in the morning session of today to Rs.894.95 on BSE from its previous close of Rs.917.50.


The company's pharmaceutical sales jumped to Rs.583.15 crore during 16 months ended March 2011 from Rs.254.82 crore during 8 months period and its sales from others comprising of OTC pharmaceuticals, cosmetics and allied consumer products increased to Rs.56.55 crore from Rs.34.28 crore.


Wyeth's reserves & surplus increased to Rs.362.04 crore from Rs.254.80 crore in the previous year of 8 months period. The company's inventories reached at Rs.74.62 crore from Rs.59.69 crore.